Angina rarely arrives as a dramatic event. For most people it starts as tightness on the walk up the driveway, a heaviness that shows up on a brisk walk and eases when they stop, or a pressure that appears in cold weather. Over time it quietly narrows a life. Stairs get avoided. Hikes get skipped. Nitroglycerin goes everywhere.
If you have already tried medication, and possibly a stent or bypass, and the chest pain is still there, you are not out of options. EECP®/ECP therapy is a non-invasive outpatient treatment that has been used for angina for three decades, and for many people it restores activity they had written off.
What angina is actually telling you
Angina is chest discomfort that appears when the heart muscle is not getting as much oxygen-rich blood as it needs. Most often the cause is narrowing in one or more coronary arteries, though it can also occur with valve disease, hypertrophic cardiomyopathy, or long-standing high blood pressure.
The frustrating category is refractory angina. That is angina that persists despite maximum medication, or in people who are not good candidates for stenting or bypass surgery. This is exactly the group EECP®/ECP was developed for.
What EECP®/ECP therapy is
EECP®/ECP stands for enhanced external counterpulsation. It received US Food and Drug Administration approval in 1995 and was first introduced as a treatment for angina before being applied to heart failure, ischemic cerebrovascular disease and cardiomyopathy. nih
You lie on a padded treatment table while three sets of inflatable cuffs are wrapped around your calves, lower thighs and upper thighs. ECG electrodes read your heartbeat, and the cuffs inflate and deflate in time with it. There is no incision, no anaesthetic and no recovery period.
How it eases angina
The cuffs apply sequential pneumatic compression to the lower limbs during diastole, the resting phase of the heartbeat, which improves coronary perfusion while reducing the workload on the left ventricle. There are two effects, one immediate and one that builds. Aetna
In the short term, the therapy delivers more oxygen to the oxygen-starved heart muscle by increasing coronary blood flow during diastole, while at the same time lowering the heart's oxygen demand by reducing how hard it has to work. The longer-term benefit is thought to come from increased collateral flow to those same regions of the heart, along with improved endothelial function. Aetna
Collaterals are the small natural bypass channels your body can build around a narrowed artery. Encouraging them is the reason benefits often continue long after the last session.
What the research shows
The MUlti-center STudy of Enhanced External Counter Pulsation, known as MUST-EECP, was the first multi-centre prospective randomised controlled trial to look at the effect of the therapy in stable angina. It studied a genuinely difficult group. More than 70 percent of participants had already undergone angioplasty or bypass surgery, 51 percent had a history of heart attack, 70 percent had Canadian Cardiovascular Society grade II or III angina, and 65 percent had multi-vessel disease. Results showed significant improvement in exercise tolerance, time to 1 mm ST segment depression, frequency of angina attacks and nitroglycerin use. nih
A later randomised sham-controlled study published in Circulation added mechanistic detail. Among 42 patients with symptomatic coronary artery disease, the therapy reduced anginal episodes, nitrate use and Canadian Cardiovascular Society angina class, alongside measurable improvements in blood vessel dilation capacity and levels of endothelium-derived vasoactive agents. AHA Journals
It is worth being straight about how the guidelines read this evidence. The American College of Cardiology and American Heart Association guidelines on stable ischemic heart disease state that the therapy may be considered for the relief of refractory angina, a Class IIb, Level of Evidence B recommendation, meaning efficacy is not fully established and further study would be useful. That position has been carried forward unchanged in subsequent reviews. For people who have run out of surgical options, a well-tolerated therapy with this evidence base is still worth serious consideration. BcbsncCigna
Reported experience suggests that patients who respond well may see lasting benefit for up to five years after treatment, which is part of why it is viewed as a cost-effective long-term option for chronic angina. nih
What a full course involves
The standard course is 35 hours of treatment, delivered as roughly five hours per week in one to two hour sessions over seven weeks. An accelerated schedule uses two one-hour sessions per day, separated by at least 30 minutes, compressing the same 35 hours into about three and a half weeks. Repeat courses can be given later when clinically appropriate, following the same protocol. Aetna
Consistency matters more than speed. The collateral development that drives the durable benefit depends on completing the full course.
What a session feels like
Most people describe it as a strong, rhythmic squeeze that travels up the legs, closer to a firm sports massage than anything uncomfortable. You stay fully clothed in loose trousers. You can read, listen to a podcast, or talk with the staff. When the hour is up you get off the table and carry on with your day. Some people feel a little leg fatigue in the first week, which usually settles.
Who tends to be a good candidate
- People with chronic stable angina who still have symptoms on optimal medication
- People who are not suitable for stenting or bypass, or who face high risk of complications from them
- People who have already had procedures and whose chest pain has returned
- People who want to strengthen circulation alongside their existing cardiac care
Insurance coverage commonly follows a similar profile, with a course of up to 35 sessions covered for disabling angina classified as New York Heart Association Class III or IV that is refractory to maximum medical therapy and not readily suitable for angioplasty or bypass. Coverage varies by plan, so check yours. Bcbsnc
Who it is not suitable for
Screening is not a formality. The therapy is generally avoided in people with certain arrhythmias that stop the equipment triggering accurately from the ECG, significant aortic valve regurgitation, an aortic aneurysm requiring repair, active blood clots or deep vein thrombosis, severe peripheral arterial disease, uncontrolled high blood pressure, some bleeding conditions, and during pregnancy. A full cardiac assessment comes before any session is booked.
Where it fits in a wider plan
At CoCardio®, EECP®/ECP is not offered as a standalone fix. It sits alongside our B.E.H.A.P.P.Y method, which addresses the habits and root causes behind the disease, plus heart function testing so progress is measured rather than assumed. That combination is what makes CoCardio® the premier preventive heart care option in Encinitas.
The therapy is also intended as an adjunct to standard medical care rather than a replacement for it. Nobody should stop or change a prescribed medication without speaking to the doctor who prescribed it.
Common questions
Is it painful? No. It is a firm pressure sensation, not pain.
How soon will I notice a difference? Many people report changes partway through the course, though the fuller benefit usually shows once all 35 hours are complete.
Can I have it if I have already had a stent or bypass? Yes. In the main clinical trial, more than 70 percent of participants had already had one or the other. nih
Will I be able to reduce my medication? That is a decision for your prescribing physician, based on how your symptoms and testing respond.
How long do the results last? Responders may experience benefit for several years, with reports of up to five. nih
Take the next step
If angina is deciding what you can and cannot do, it is worth finding out whether EECP® therapy for angina fits your situation. Book a Root Cause Heart Health Consultation at our Encinitas centre, or call 858-500-1399.
CoCardio® Inc can be an adjunct to standard medical care and is not a replacement for care by your cardiologist. EECP is a registered trademark of Vasomedical, Inc. This content is for educational purposes only. Speak with a qualified healthcare professional before starting any therapy or changing your healthcare, diet or lifestyle.